BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 31481087)

  • 1. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
    Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas.
    Wang Y; Fu D; Chen Y; Su J; Wang Y; Li X; Zhai W; Niu Y; Yue D; Geng H
    Cell Death Dis; 2018 May; 9(5):501. PubMed ID: 29717134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YBX1 knockdown induces renal cell carcinoma cell apoptosis via Kindlin-2.
    Cui Q; Wang C; Liu S; Du R; Tian S; Chen R; Geng H; Subramanian S; Niu Y; Wang Y; Yue D
    Cell Cycle; 2021 Nov; 20(22):2413-2427. PubMed ID: 34709966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
    Wang Z; Chang X; Zhu G; Gao X; Chang L
    Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orf Virus ORF120 Protein Positively Regulates the NF-κB Pathway by Interacting with G3BP1.
    Zhou Y; Guan J; Gao F; Li Z; Lan Y; Lu H; Song D; Lv L; Lv P; Xu M; Wang Z; He H; Zhao K; He W
    J Virol; 2021 Sep; 95(19):e0015321. PubMed ID: 34287041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways.
    Zhang LN; Zhao L; Yan XL; Huang YH
    J Cell Physiol; 2019 Nov; 234(11):20469-20484. PubMed ID: 30989663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.
    Yue D; Wang Y; Sun Y; Niu Y; Chang C
    Neoplasia; 2017 Feb; 19(2):135-144. PubMed ID: 28107702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway.
    Mi K; Zeng L; Chen Y; Ning J; Zhang S; Zhao P; Yang S
    Cell Signal; 2024 Jan; 113():110962. PubMed ID: 37931691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of G3BP1 associates with YB1 and p-AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection.
    Zheng H; Zhan Y; Zhang Y; Liu S; Lu J; Yang Y; Wen Q; Fan S
    Cancer Med; 2019 Nov; 8(16):6894-6903. PubMed ID: 31560169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of G3BP1 facilitates the progression of colon cancer by activating β‑catenin signaling.
    Li Y; Wang J; Zhong S; Li J; Du W
    Mol Med Rep; 2020 Nov; 22(5):4403-4411. PubMed ID: 33000280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CARD10 promotes the progression of renal cell carcinoma by regulating the NF‑κB signaling pathway.
    Peng L; He K; Cao Z; Bi L; Yu D; Wang Q; Wang J
    Mol Med Rep; 2020 Jan; 21(1):329-337. PubMed ID: 31939627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 + T cells promote renal cell carcinoma proliferation via modulating YBX1.
    Wang Y; Wang Y; Xu L; Lu X; Fu D; Su J; Geng H; Qin G; Chen R; Quan C; Niu Y; Yue D
    Exp Cell Res; 2018 Feb; 363(1):95-101. PubMed ID: 29289594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SPOCD1-AS from ovarian cancer extracellular vesicles remodels mesothelial cells to promote peritoneal metastasis via interacting with G3BP1.
    Wang C; Wang J; Shen X; Li M; Yue Y; Cheng X; Lu W; Wang X; Xie X
    J Exp Clin Cancer Res; 2021 Mar; 40(1):101. PubMed ID: 33726799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53.
    Mao C; Wang X; Liu Y; Wang M; Yan B; Jiang Y; Shi Y; Shen Y; Liu X; Lai W; Yang R; Xiao D; Cheng Y; Liu S; Zhou H; Cao Y; Yu W; Muegge K; Yu H; Tao Y
    Cancer Res; 2018 Jul; 78(13):3484-3496. PubMed ID: 29588351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-κB pathway in cholangiocarcinoma.
    Jiang W; Wang J; Yang X; Shan J; Zhang Y; Shi X; Wang Y; Chenyan A; Chang J; Wang Y; Yu Y; Li C; Li X
    Oncogene; 2023 Apr; 42(17):1392-1404. PubMed ID: 36922675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C1QBP negatively regulates the activation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomics analysis.
    Wang Y; Yue D; Xiao M; Qi C; Chen Y; Sun D; Zhang N; Chen R
    J Proteome Res; 2015 Feb; 14(2):804-13. PubMed ID: 25497084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of Circ_0000798 Impedes Cell Growth and Motility of Renal Cell Carcinoma Cells Through Functioning as miRNA Sponge for miR-589-5p.
    Li Z; Zheng J; Xu J; Niu Q
    Biochem Genet; 2023 Feb; 61(1):279-298. PubMed ID: 35857217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Ras GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) inhibits the progression of ovarian cancer in coordination with ubiquitin-specific protease 10 (USP10).
    Li M; Tang Y; Zuo X; Meng S; Yi P
    Bioengineered; 2022 Jan; 13(1):721-734. PubMed ID: 34967276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of RICTOR gene transcription by the proinflammatory cytokines through NF-κB pathway contributes to the metastasis of renal cell carcinoma.
    Sun B; Chen L; Fu H; Guo L; Guo H; Zhang N
    Tumour Biol; 2016 Apr; 37(4):4457-66. PubMed ID: 26500094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.